Celina Tizuko Fujiyama Oshima Selected Research

Celina Tizuko Fujiyama Oshima Research Topics

Disease

12	Neoplasms (Cancer) 02/2020 - 02/2009
8	Carcinogenesis 02/2020 - 02/2013
7	Inflammation (Inflammations) 03/2020 - 10/2008
6	Colitis 04/2018 - 08/2009
4	Colorectal Neoplasms (Colorectal Cancer) 04/2016 - 09/2010
3	Stomach Neoplasms (Stomach Cancer) 02/2020 - 04/2008
3	Carcinoma (Carcinomatosis) 01/2019 - 06/2014
3	Adenocarcinoma 11/2016 - 02/2013
2	Crohn Disease (Crohn's Disease) 10/2020 - 10/2008
2	Adenoma (Adenomas) 04/2016 - 06/2009
2	Mouth Neoplasms (Oral Cancer) 04/2014 - 11/2009
2	Necrosis 10/2011 - 01/2008
2	Reperfusion Injury 01/2008 - 01/2008
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 02/2020
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 04/2016
1	Body Weight (Weight, Body) 11/2014
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2014
1	Esophageal Squamous Cell Carcinoma 01/2013
1	Hypoxia (Hypoxemia) 01/2013
1	Pain (Aches) 05/2012
1	Rectal Neoplasms (Rectal Cancer) 03/2011
1	Endometrial Neoplasms (Endometrial Cancer) 01/2011
1	Ovarian Neoplasms (Ovarian Cancer) 02/2009
1	Atrophy 10/2008
1	Ischemia 01/2008
1	Fibroadenoma 11/2007

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 04/2019 - 10/2008
5	salicylhydroxamic acid (SHAM)IBA 04/2018 - 08/2009
4	Sulfonic AcidsIBA 03/2014 - 08/2009
4	sym-trinitrobenzeneIBA 03/2014 - 08/2009
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2019 - 03/2014
3	beta CateninIBA 04/2016 - 02/2009
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 06/2012 - 08/2009
2	Cyclin D1IBA 02/2020 - 01/2019
2	Caspase 3 (Caspase-3)IBA 09/2019 - 02/2013
2	UbiquitinIBA 01/2019 - 04/2016
2	AzoxymethaneIBA 11/2015 - 02/2015
2	AntioxidantsIBA 01/2015 - 05/2014
2	Biomarkers (Surrogate Marker)IBA 07/2014 - 11/2009
2	Galectin 3 (LGALS3)IBA 07/2014 - 12/2011
2	ParaffinIBA 06/2014 - 02/2013
2	lumiracoxib (prexige)IBA 06/2012 - 08/2009
2	Etanercept (Enbrel)FDA Link 06/2012 - 10/2011
1	DNA (Deoxyribonucleic Acid)IBA 10/2020
1	Biological ProductsIBA 03/2020
1	CateninsIBA 02/2020
1	Proto-Oncogene Proteins c-mycIBA 02/2020
1	Interleukin-2 (IL2)IBA 04/2019
1	Interleukin-6 (Interleukin 6)IBA 04/2019
1	Interleukin-10 (Interleukin 10)IBA 04/2019
1	FluoridesIBA 06/2017
1	Cadherins (E-Cadherin)IBA 11/2016
1	SurvivinIBA 11/2016
1	AntibodiesIBA 04/2016
1	amsonic acid (DAS)IBA 04/2016
1	EnzymesIBA 01/2015
1	CatalaseIBA 01/2015
1	PolyphenolsIBA 11/2014
1	Cadmium Chloride (Cadmium Dichloride)IBA 11/2014
1	ErbB Receptors (EGF Receptor)IBA 04/2014
1	CytokinesIBA 03/2014
1	Cytochromes c (Cytochrome c)IBA 02/2013
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2013
1	Molecular Chaperones (Chaperone, Molecular)IBA 01/2013
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 05/2012
1	Fluorouracil (Carac)FDA LinkGeneric 03/2011
1	AcetyltransferasesIBA 02/2011
1	Pharmaceutical PreparationsIBA 06/2009
1	Fingolimod Hydrochloride (FTY720)FDA Link 06/2009
1	Urethane (Ethyl Carbamate)IBA 06/2009
1	Cyclooxygenase 1IBA 10/2008
1	MucinsIBA 10/2008
1	CollagenIBA 10/2008
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2008
1	CarbohydratesIBA 04/2008
1	NitratesIBA 04/2008
1	SaltsIBA 04/2008
1	SugarsIBA 04/2008
1	SodiumIBA 01/2008
1	CreatinineIBA 01/2008
1	PotassiumIBA 01/2008
1	Pentoxifylline (Trental)FDA LinkGeneric 01/2008
1	Saline SolutionIBA 01/2008
1	Xylazine (Xylazin)IBA 01/2008
1	Urea (Carbamide)FDA LinkGeneric 01/2008
1	Oxygen (Dioxygen)IBA 01/2008
1	Ketamine FDA LinkGeneric 01/2008
1	Estriol (Epiestriol)IBA 11/2007
1	Oral ContraceptivesIBA 11/2007
1	AntigensIBA 11/2007

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 02/2013 - 09/2010
2	Therapeutics 10/2011 - 09/2010
1	Gastrectomy 11/2016
1	Intraperitoneal Injections 11/2014
1	Immunomodulation 07/2014
1	Radiotherapy 02/2013
1	Neoadjuvant Therapy 03/2011
1	Aftercare (After-Treatment) 03/2011
1	Adjuvant Chemotherapy 09/2010
1	Anesthesia 01/2008